1
|
Beta-cell adaptation and decompensation during the progression of diabetes.
|
Diabetes
|
2001
|
1.81
|
2
|
A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat.
|
Diabetes
|
1994
|
1.40
|
3
|
High glucose stimulates early response gene c-Myc expression in rat pancreatic beta cells.
|
J Biol Chem
|
2001
|
1.11
|
4
|
Reduced endoplasmic reticulum (ER)-to-Golgi protein trafficking contributes to ER stress in lipotoxic mouse beta cells by promoting protein overload.
|
Diabetologia
|
2009
|
1.11
|
5
|
The influence of genetic background on the induction of oxidative stress and impaired insulin secretion in mouse islets.
|
Diabetologia
|
2006
|
1.10
|
6
|
Cytosolic citrate and malonyl-CoA regulation in rat muscle in vivo.
|
Am J Physiol
|
1999
|
0.97
|
7
|
Differential regulation of adaptive and apoptotic unfolded protein response signalling by cytokine-induced nitric oxide production in mouse pancreatic beta cells.
|
Diabetologia
|
2011
|
0.92
|
8
|
Pharmacological reduction of NEFA restores the efficacy of incretin-based therapies through GLP-1 receptor signalling in the beta cell in mouse models of diabetes.
|
Diabetologia
|
2012
|
0.90
|
9
|
Deletion of protein kinase Cδ in mice modulates stability of inflammatory genes and protects against cytokine-stimulated beta cell death in vitro and in vivo.
|
Diabetologia
|
2010
|
0.86
|
10
|
Cross-talk between the unfolded protein response and nuclear factor-κB signalling pathways regulates cytokine-mediated beta cell death in MIN6 cells and isolated mouse islets.
|
Diabetologia
|
2012
|
0.82
|
11
|
Malonyl CoA as a metabolic switch and a regulator of insulin sensitivity.
|
Adv Exp Med Biol
|
1998
|
0.77
|